US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist
  • 0.1338
  • -0.0313-18.96%
Close Nov 22 16:00 ET
  • 0.1346
  • +0.0008+0.60%
Post 19:57 ET
25.85MMarket Cap-557P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.63%10.63M
2.67%10.97M
28.84%9.34M
10.25%36.73M
34.11%10.12M
-2.74%8.67M
40.77%10.69M
-21.70%7.25M
41.58%33.32M
45.09%7.55M
Selling and administrative expenses
60.38%7.87M
23.59%7.36M
76.61%6.72M
39.92%21.91M
96.14%7.24M
21.82%4.91M
43.98%5.96M
0.08%3.8M
38.69%15.66M
26.93%3.69M
-General and administrative expense
60.38%7.87M
23.59%7.36M
76.61%6.72M
39.92%21.91M
96.14%7.24M
21.82%4.91M
43.98%5.96M
0.08%3.8M
38.69%15.66M
26.93%3.69M
Research and development costs
-26.58%2.76M
-23.71%3.61M
-23.90%2.62M
-16.06%14.82M
-25.27%2.88M
-22.98%3.76M
36.92%4.73M
-36.87%3.45M
44.24%17.66M
68.13%3.86M
Operating profit
-22.63%-10.63M
-2.67%-10.97M
-28.84%-9.34M
-10.25%-36.73M
-34.11%-10.12M
2.74%-8.67M
-40.77%-10.69M
21.70%-7.25M
-41.58%-33.32M
-45.09%-7.55M
Net non-operating interest income expense
-39.18%204.84K
-39.92%182.21K
18.22%253.64K
369.14%1.18M
140.91%324.81K
535.19%336.78K
925.58%303.28K
531.36%214.55K
0.16%251.4K
78.34%134.83K
Non-operating interest income
-39.18%204.84K
-39.92%182.21K
18.22%253.64K
369.14%1.18M
140.91%324.81K
535.19%336.78K
925.58%303.28K
531.36%214.55K
-3.98%251.4K
78.34%134.83K
Other net income (expense)
2.39M
3.59M
0
3.59M
Other non- operating income (expenses)
----
--2.39M
----
--3.59M
--0
----
----
--3.59M
----
----
Income before tax
-25.12%-10.43M
19.09%-8.4M
-163.42%-9.09M
3.32%-31.97M
-32.17%-9.8M
5.96%-8.34M
-37.31%-10.38M
62.61%-3.45M
-43.42%-33.06M
-49.46%-7.41M
Income tax
0.00%144K
0.00%144K
0.00%144K
0.00%576K
-75.00%144K
144K
144K
144K
576K
576K
Net income
-24.70%-10.57M
18.83%-8.54M
-156.88%-9.23M
3.26%-32.54M
-24.44%-9.94M
4.34%-8.48M
-39.21%-10.53M
61.05%-3.59M
-45.92%-33.64M
-61.07%-7.99M
Net income continuous Operations
-24.70%-10.57M
18.83%-8.54M
-156.88%-9.23M
3.26%-32.54M
-24.44%-9.94M
4.34%-8.48M
-39.21%-10.53M
61.05%-3.59M
-45.92%-33.64M
-61.07%-7.99M
Minority interest income
Net income attributable to the parent company
-24.70%-10.57M
18.83%-8.54M
-156.88%-9.23M
3.26%-32.54M
-24.44%-9.94M
4.34%-8.48M
-39.21%-10.53M
61.05%-3.59M
-45.92%-33.64M
-61.07%-7.99M
Preferred stock dividends
Other preferred stock dividends
321.56K
1.15M
1.15M
0
0
Net income attributable to common stockholders
-28.49%-10.89M
18.83%-8.54M
-156.88%-9.23M
-0.16%-33.69M
-38.85%-11.1M
4.34%-8.48M
-39.21%-10.53M
61.05%-3.59M
-37.28%-33.64M
-61.07%-7.99M
Basic earnings per share
0.00%-0.06
28.57%-0.05
-200.00%-0.06
4.35%-0.22
-40.00%-0.07
0.00%-0.06
-40.00%-0.07
66.67%-0.02
0.00%-0.23
-66.67%-0.05
Diluted earnings per share
0.00%-0.06
28.57%-0.05
-200.00%-0.06
4.35%-0.22
-40.00%-0.07
0.00%-0.06
-40.00%-0.07
66.67%-0.02
0.00%-0.23
-66.67%-0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.63%10.63M2.67%10.97M28.84%9.34M10.25%36.73M34.11%10.12M-2.74%8.67M40.77%10.69M-21.70%7.25M41.58%33.32M45.09%7.55M
Selling and administrative expenses 60.38%7.87M23.59%7.36M76.61%6.72M39.92%21.91M96.14%7.24M21.82%4.91M43.98%5.96M0.08%3.8M38.69%15.66M26.93%3.69M
-General and administrative expense 60.38%7.87M23.59%7.36M76.61%6.72M39.92%21.91M96.14%7.24M21.82%4.91M43.98%5.96M0.08%3.8M38.69%15.66M26.93%3.69M
Research and development costs -26.58%2.76M-23.71%3.61M-23.90%2.62M-16.06%14.82M-25.27%2.88M-22.98%3.76M36.92%4.73M-36.87%3.45M44.24%17.66M68.13%3.86M
Operating profit -22.63%-10.63M-2.67%-10.97M-28.84%-9.34M-10.25%-36.73M-34.11%-10.12M2.74%-8.67M-40.77%-10.69M21.70%-7.25M-41.58%-33.32M-45.09%-7.55M
Net non-operating interest income expense -39.18%204.84K-39.92%182.21K18.22%253.64K369.14%1.18M140.91%324.81K535.19%336.78K925.58%303.28K531.36%214.55K0.16%251.4K78.34%134.83K
Non-operating interest income -39.18%204.84K-39.92%182.21K18.22%253.64K369.14%1.18M140.91%324.81K535.19%336.78K925.58%303.28K531.36%214.55K-3.98%251.4K78.34%134.83K
Other net income (expense) 2.39M3.59M03.59M
Other non- operating income (expenses) ------2.39M------3.59M--0----------3.59M--------
Income before tax -25.12%-10.43M19.09%-8.4M-163.42%-9.09M3.32%-31.97M-32.17%-9.8M5.96%-8.34M-37.31%-10.38M62.61%-3.45M-43.42%-33.06M-49.46%-7.41M
Income tax 0.00%144K0.00%144K0.00%144K0.00%576K-75.00%144K144K144K144K576K576K
Net income -24.70%-10.57M18.83%-8.54M-156.88%-9.23M3.26%-32.54M-24.44%-9.94M4.34%-8.48M-39.21%-10.53M61.05%-3.59M-45.92%-33.64M-61.07%-7.99M
Net income continuous Operations -24.70%-10.57M18.83%-8.54M-156.88%-9.23M3.26%-32.54M-24.44%-9.94M4.34%-8.48M-39.21%-10.53M61.05%-3.59M-45.92%-33.64M-61.07%-7.99M
Minority interest income
Net income attributable to the parent company -24.70%-10.57M18.83%-8.54M-156.88%-9.23M3.26%-32.54M-24.44%-9.94M4.34%-8.48M-39.21%-10.53M61.05%-3.59M-45.92%-33.64M-61.07%-7.99M
Preferred stock dividends
Other preferred stock dividends 321.56K1.15M1.15M00
Net income attributable to common stockholders -28.49%-10.89M18.83%-8.54M-156.88%-9.23M-0.16%-33.69M-38.85%-11.1M4.34%-8.48M-39.21%-10.53M61.05%-3.59M-37.28%-33.64M-61.07%-7.99M
Basic earnings per share 0.00%-0.0628.57%-0.05-200.00%-0.064.35%-0.22-40.00%-0.070.00%-0.06-40.00%-0.0766.67%-0.020.00%-0.23-66.67%-0.05
Diluted earnings per share 0.00%-0.0628.57%-0.05-200.00%-0.064.35%-0.22-40.00%-0.070.00%-0.06-40.00%-0.0766.67%-0.020.00%-0.23-66.67%-0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data